https://www.selleckchem.com/pr....oducts/alpha-cyano-4
The diagnostic criteria of POEMS syndrome may thus need further investigation. Real-world evidence to support optimal ustekinumab dosing for refractory Crohn's disease (CD) patients remains limited. Data from a retrospective nationwide chart review study was utilized to explore ustekinumab dosing dynamics and optimization, identify possible clinical predictors of dose intensification, and to evaluate ustekinumab trough concentrations (TCs) and concomitant medication use in Finland. Information gathe
Like
Comment
Share
